Increase the Qelbree Dose
After 4 weeks without improvement, you should increase the viloxazine dose, as the current regimen has likely not reached therapeutic levels for this patient. 1
Dosing Strategy for Adolescents
For a 13-year-old, the FDA-approved dosing approach is:
- Starting dose: 200 mg once daily
- Titration: Increase by 100 mg weekly increments based on response and tolerability
- Target range: 400-600 mg once daily (maximum 600 mg/day for adolescents) 1
Most adolescents require 400 mg/day for optimal response based on clinical trial data showing this was the median modal dose in long-term studies 2. The 200 mg dose showed efficacy but 400 mg demonstrated superior symptom reduction in phase 3 trials 3.
Timeline Expectations
A critical pitfall here is expecting immediate results. Viloxazine requires 4-6 weeks to reach full therapeutic effect 4, 5. However, early response at week 2 predicts week 6 outcomes with 75% accuracy 5. Since your patient shows no improvement at 4 weeks, this suggests inadequate dosing rather than non-response.
The dose-response curve for viloxazine is bell-shaped, with optimal efficacy between 200-400 mg (or 6-8 mg/kg), and doses above 400 mg may not provide additional benefit 4. For a typical 13-year-old, 400 mg represents the therapeutic sweet spot.
Monitoring During Titration
Before increasing the dose, assess 1:
- Blood pressure and heart rate (viloxazine increases both; 22-34% of adolescents experience ≥20 bpm heart rate increases)
- Suicidal ideation using structured assessment (increased risk during dose changes)
- Somnolence/fatigue (most common adverse effect that may worsen with higher doses)
- Appetite and weight (decreased appetite occurs in ~6% of patients)
Alternative Considerations
If the patient cannot tolerate dose escalation or shows no response at 400 mg after 6 weeks total treatment:
Switch to a stimulant medication (methylphenidate or amphetamine), which remain first-line therapy per AAP guidelines with larger effect sizes than non-stimulants 6, 7. Viloxazine is appropriately used as second-line therapy or when stimulants are contraindicated (substance use concerns, tic disorders, or patient/family preference for non-stimulants) 6, 7.
The 2019 AAP guidelines emphasize that while behavioral therapy combined with medication offers advantages for comorbid conditions and family satisfaction, medication alone provides the most robust improvement in core ADHD symptoms 6. For adolescents specifically, ensure medication coverage extends to driving hours given crash risks 6.
Practical Next Steps
- Increase to 400 mg once daily immediately
- Reassess at week 6 (2 weeks post-increase)
- If partial response, consider 600 mg (maximum adolescent dose)
- If no response by week 8 total, transition to stimulant therapy
The most common error is abandoning viloxazine prematurely before adequate dosing and duration. However, do not persist beyond 8 weeks total without meaningful improvement—this represents treatment failure requiring medication class change 7.